Esperion Therapeutics CFO, CEO, and CLO sell shares on March 17, 2026.

Esperion Therapeutics, Inc. has recently disclosed certain transactions involving its executives. Specifically, Chief Financial Officer Halladay Benjamin has sold 6,424 shares at a price of $2.71 per share on March 17, 2026. Additionally, Director, President and CEO Koenig Sheldon L. has sold 25,578 shares at a price of $2.72 per share on the same date. Furthermore, Chief Legal Officer Looker Benjamin has sold 5,708 shares at a price of $2.7 per share on March 17, 2026. These transactions may be of interest to investors and stakeholders looking for insight into the company's financial activities.